Please login to the form below

Not currently logged in
Email:
Password:

ADA 2013

This page shows the latest ADA 2013 news and features for those working in and with pharma, biotech and healthcare.

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

ADA: Boehringer/ Lilly's empagliflozin shows blood glucose benefits

When taken together, the trials, which were presented over the weekend at the American Diabetes Association's (ADA) Scientific Sessions in Chicago, showed “a very consistent efficacy profile of the drug ... in full at next year's ADA meeting.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics